UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 248

Sortiert nach

Use of RAAS Inhibitors and Risk of Clinical Deterioration in COVID-19: Results From an Italian Cohort of 133 Hypertensives

American journal of hypertension, 2020-10, Vol.33 (10), p.944-948

2020

Volltextzugriff (PDF)

Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications

International journal of molecular sciences, 2023-02, Vol.24 (4), p.3957

2023

Volltextzugriff (PDF)

Venous thromboembolism in patients with inflammatory bowel disease:Focus on prevention and treatment

World journal of gastroenterology : WJG, 2014-03, Vol.20 (12), p.3173-3179

2014

Volltextzugriff (PDF)

Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022

Frontiers in immunology, 2023-10, Vol.14, p.1231242-1231242

2023

Volltextzugriff (PDF)

The Emerging Role of Nutraceuticals in Cardiovascular Calcification: Evidence from Preclinical and Clinical Studies

Nutrients, 2021-07, Vol.13 (8), p.2603

2021

Volltextzugriff (PDF)

Impact of Hypogammaglobulinemia on the Course of COVID-19 in a Non-Intensive Care Setting: A Single-Center Retrospective Cohort Study

Frontiers in immunology, 2022-03, Vol.13, p.842643-842643

2022

Volltextzugriff (PDF)

The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients

PloS one, 2017-03, Vol.12 (3), p.e0173664-e0173664

2017

Volltextzugriff (PDF)

Sarcoidosis versus Granulomatous and Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency: A Comparative Review

Biomedicines, 2024-07, Vol.12 (7), p.1503

2024

Volltextzugriff (PDF)

Anal Fistula Human Amniotic Membrane Endosealing (F-HAME): A Proof of Concept Study

Frontiers in surgery, 2022-03, Vol.9, p.869923-869923

2022

Volltextzugriff (PDF)

GSK-3 Inhibition Modulates Metalloproteases in a Model of Lung Inflammation and Fibrosis

Frontiers in molecular biosciences, 2021-06, Vol.8, p.633054-633054

2021

Volltextzugriff (PDF)

Biomarkers of Neutrophil Activation in Patients with Symptomatic Chronic Peripheral Artery Disease Predict Worse Cardiovascular Outcome

Biomedicines, 2023-03, Vol.11 (3), p.866

2023

Volltextzugriff (PDF)

The Importance of Endoscopy with Biopsy: Real-World Evidence of Gastrointestinal Involvement in Primary Immunodeficiency in Two Main Northern Italian Centres

Biomedicines, 2023-01, Vol.11 (1), p.170

2023

Volltextzugriff (PDF)

Adalimumab biosimilar ABP 501 is equally effective and safe in long-term management of inflammatory bowel diseases patients when used as first biologic treatment or as replace of the ADA originator for a non-medical reason

Frontiers in gastroenterology (Lausanne, Switzerland), 2023-10, Vol.2

2023

Volltextzugriff (PDF)

Comparison between Dexamethasone and Methylprednisolone Therapy in Patients with COVID-19 Pneumonia Admitted to Non-Intensive Medical Units

Journal of clinical medicine, 2021-12, Vol.10 (24), p.5812

2021

Volltextzugriff (PDF)

Surgical Management of Hemorrhoidal Disease in Inflammatory Bowel Disease: A Systematic Review with Proportional Meta-Analysis

Journal of clinical medicine, 2022-01, Vol.11 (3), p.709

2022

Volltextzugriff (PDF)

Subjective cognitive complaints, neuropsychological performance, affective and behavioural symptoms in non-demented patients

International journal of geriatric psychiatry, 2008-01, Vol.23 (1), p.95-101

2008

Volltextzugriff (PDF)

Changes in hospital admissions and complications of acute appendicitis during the COVID-19 pandemic: A systematic review and meta-analysis

Health sciences review (Oxford, England), 2022-06, Vol.3, p.100021-100021, Article 100021

2022

Volltextzugriff (PDF)

Coronavirus disease 2019 in Italy: The Veneto model

Infection control and hospital epidemiology, 2021-02, Vol.42 (2), p.236-237

2021

Volltextzugriff (PDF)

Impact of COVID-19 Outbreak on Healthcare Workers in Italy: Results from a National E-Survey

Journal of community health, 2020-08, Vol.45 (4), p.675-683

2020

Volltextzugriff (PDF)

Therapeutic Role of Appendectomy in Ulcerative Colitis: A Tangible Perspective?

Journal of Crohn's and colitis, 2019-02, Vol.13 (2), p.142-143

2019

Volltextzugriff (PDF)

Etrolizumab in moderate-to-severe ulcerative colitis

The Lancet (British edition), 2014-07, Vol.384 (9940), p.285-286

2014

Volltextzugriff (PDF)

Vascular Involvement in Inflammatory Bowel Disease: Pathogenesis and Clinical Aspects

Digestive diseases (Basel), 2008-01, Vol.26 (2), p.149-155

2008

Volltextzugriff (PDF)

What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?

World journal of gastrointestinal pharmacology and therapeutics, 2016-08, Vol.7 (3), p.387-396

2016

Volltextzugriff (PDF)

IBD: Infliximab dose optimization in IBD-proactive or reactive?

Nature reviews. Gastroenterology & hepatology, 2014-12, Vol.11 (12), p.706

2014

Volltextzugriff (PDF)

The role of healthcare providers in accompanying biosimilars in inflammatory bowel diseases

Expert opinion on biological therapy, 2019-10, Vol.19 (10), p.967-969

2019

Volltextzugriff (PDF)

1 – 25 von 248

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(214)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Use of RAAS Inhibitors and Risk of Clinical Deterioration in COVID-19: Results From an Italian Cohort of 133 Hypertensives

Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications

Venous thromboembolism in patients with inflammatory bowel disease:Focus on prevention and treatment

Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022

The Emerging Role of Nutraceuticals in Cardiovascular Calcification: Evidence from Preclinical and Clinical Studies

Impact of Hypogammaglobulinemia on the Course of COVID-19 in a Non-Intensive Care Setting: A Single-Center Retrospective Cohort Study

The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients

Sarcoidosis versus Granulomatous and Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency: A Comparative Review

Anal Fistula Human Amniotic Membrane Endosealing (F-HAME): A Proof of Concept Study

GSK-3 Inhibition Modulates Metalloproteases in a Model of Lung Inflammation and Fibrosis

Biomarkers of Neutrophil Activation in Patients with Symptomatic Chronic Peripheral Artery Disease Predict Worse Cardiovascular Outcome

The Importance of Endoscopy with Biopsy: Real-World Evidence of Gastrointestinal Involvement in Primary Immunodeficiency in Two Main Northern Italian Centres

Adalimumab biosimilar ABP 501 is equally effective and safe in long-term management of inflammatory bowel diseases patients when used as first biologic treatment or as replace of the ADA originator for a non-medical reason

Comparison between Dexamethasone and Methylprednisolone Therapy in Patients with COVID-19 Pneumonia Admitted to Non-Intensive Medical Units

Surgical Management of Hemorrhoidal Disease in Inflammatory Bowel Disease: A Systematic Review with Proportional Meta-Analysis

Subjective cognitive complaints, neuropsychological performance, affective and behavioural symptoms in non-demented patients

Changes in hospital admissions and complications of acute appendicitis during the COVID-19 pandemic: A systematic review and meta-analysis

Coronavirus disease 2019 in Italy: The Veneto model

Impact of COVID-19 Outbreak on Healthcare Workers in Italy: Results from a National E-Survey

Therapeutic Role of Appendectomy in Ulcerative Colitis: A Tangible Perspective?

Etrolizumab in moderate-to-severe ulcerative colitis

Vascular Involvement in Inflammatory Bowel Disease: Pathogenesis and Clinical Aspects

What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?

IBD: Infliximab dose optimization in IBD-proactive or reactive?

The role of healthcare providers in accompanying biosimilars in inflammatory bowel diseases

Suchergebnisse filtern